Cytosorbents (CTSO) Cash from Investing Activities (2010 - 2026)
Cytosorbents (CTSO) reported Cash from Investing Activities of -$46000.0 for Q1 2026, up 2.13% on a YoY basis from -$45041.7 in Q1 2025, and up 84.19% quarter-over-quarter from -$291000.0 in Q4 2025.
Cytosorbents (CTSO) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Cytosorbents has reported Cash from Investing Activities for 17 years, with the latest figure at -$46000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 2.13% year-over-year to -$46000.0; the trailing twelve-month figure through Mar 2026 stood at -$414000.0 (up 29.71% YoY), and the FY2025 full-year result was -$415000.0, up 37.97% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$46000.0, up from -$291000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $140285.0 in Q2 2023, with the low at -$4.7 million in Q2 2022.
- Historically, Cash from Investing Activities has averaged -$501283.1 across 5 years, with a median of -$135922.0 in 2023.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 375.79% — and 2025, when it jumped 118.39%.
- Cytosorbents' Cash from Investing Activities stood at -$206080.0 in 2022, then surged by 34.04% to -$135922.0 in 2023, then increased by 8.77% to -$124000.0 in 2024, then tumbled by 134.68% to -$291000.0 in 2025, then jumped by 84.19% to -$46000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$46000.0 (Q1 2026), -$291000.0 (Q4 2025), and $55000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Cytosorbents | 28.80 Mn | 24.00 Mn | 6.13 Mn | -46,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46,000.00 |
| Mar 31, 2026 | -46,000.00 |
| Dec 31, 2025 | -291,000.00 |
| Dec 31, 2025 | -291,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Jun 30, 2025 | -132,000.00 |
| Jun 30, 2025 | -132,000.00 |
| Mar 31, 2025 | -47,000.00 |
| Mar 31, 2025 | -47,000.00 |
| Dec 31, 2024 | -124,000.00 |
| Dec 31, 2024 | -124,000.00 |
| Sep 30, 2024 | -299,000.00 |
| Sep 30, 2024 | -299,000.00 |
| Jun 30, 2024 | -118,982.00 |
| Jun 30, 2024 | -118,982.00 |
| Mar 31, 2024 | -127,018.00 |
| Mar 31, 2024 | -127,018.00 |
| Dec 31, 2023 | -135,922.00 |
| Dec 31, 2023 | -135,922.00 |